Adaptimmune Therapeutics shares owned by Key Client Fiduciary Advisors
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Key Client Fiduciary Advisors
from 13F filings
Historical chart of Key Client Fiduciary Advisors investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Key Client Fiduciary Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Key Client Fiduciary Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $425k | 269k | 1.58 |
| 2023-12-31 | $267k | 337k | 0.79 |
| 2023-09-30 | $247k | 316k | 0.78 |
| 2023-06-30 | $305k | 329k | 0.93 |
| 2023-03-31 | $350k | 321k | 1.09 |
| 2022-12-31 | $433k | 297k | 1.46 |
| 2022-09-30 | $469k | 436k | 1.08 |
| 2022-06-30 | $707k | 416k | 1.70 |
| 2022-03-31 | $866k | 420k | 2.06 |
| 2021-12-31 | $1.0M | 266k | 3.80 |
More positions owned by Key Client Fiduciary Advisors
View all positions for Key Client Fiduciary Advisors